Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...
However, most new metastases were treated with repeated stereotactic radiation or did not require treatment. In addition, only 3.2% of patients had a recurrence in a tumor treated with stereotactic ...
SAN FRANCISCO, September 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage ...
Please provide your email address to receive an email when new articles are posted on . Stereotactic body radiation therapy followed by sorafenib extended survival compared with sorafenib alone among ...
International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and Study We received 395 responses from radiation oncologists ...
SBRT and surgery showed similar overall survival in stage I NSCLC, offering a non-invasive option for high-risk surgical patients. Surgery demonstrated better disease-free and recurrence-free survival ...
In patients with 5-20 brain metastases, stereotactic radiation improved symptoms and reduced interference with daily functioning compared to hippocampal-avoidance whole brain radiation. The weighted ...
What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?
David Kok has a clinical appointment at Peter MacCallum Cancer Centre which provides prostate cancer treatments including stereotactic radiotherapy, conventional radiotherapy and surgery. Sathana ...
Advancements in radiation therapy, including proton therapy and stereotactic radiation, reduce side effects and improve quality of life for GI cancer. Radiation therapy can be an intimidating concept ...
SAN FRANCISCO — A focused form of radiation akin to that used to destroy solid tumors may be effective at controlling high-risk ventricular arrhythmias in patients who failed to respond to an initial ...
In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results